promote international regulatory convergence between the EMA and other regulatory agencies such as the US Food and Drug Administration (FDA) and the Japan Pharmaceuticals and Medical Devices Agency (PMDA) on development plans for new promising antimicrobials.
tippromwovi l-konverġenza regolatorja internazzjonali bejn l-EMA u aġenziji regolatorji oħra bħall-US Food and Drug Administration (FDA) u l-Japan Pharmaceuticals u l-Medical Devices Agency (PMDA) dwar il-pjanijiet ta' żvilupp ta' antimikrobiċi ġodda promettenti.